COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Arcadia Project Seminars > Thinking Like a Dandelion: Cory Doctorow on copyright, Creative Commons and creativity
Thinking Like a Dandelion: Cory Doctorow on copyright, Creative Commons and creativityAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Professor John Naughton. Please email mh569@cam.ac.uk if you are planning to attend. This is the opening talk in the Arcadia Project 2009-10 Seminar series. Cory Doctorow (craphound.com) is a science fiction novelist, blogger and technology activist. He is the co-editor of the popular weblog Boing Boing (boingboing.net), and a contributor to Wired, Popular Science, Make, the New York Times, and many other newspapers, magazines and websites. He was formerly Director of European Affairs for the Electronic Frontier Foundation (eff.org), a non-profit civil liberties group that defends freedom in technology law, policy, standards and treaties. He is a Visting Senior Lecturer at Open University (UK); in 2007, he served as the Fulbright Chair at the Annenberg Center for Public Diplomacy at the University of Southern California. His novels are published by Tor Books and HarperCollins UK and simultaneously released on the Internet under Creative Commons licenses that encourage their re-use and sharing, a move that increases his sales by enlisting his readers to help promote his work. He has won the Locus and Sunburst Awards, and been nominated for the Hugo, Nebula and British Science Fiction Awards. His latest novel, New York Times Bestseller LITTLE BROTHER , was published in May 2008, and his latest short story collection is OVERCLOCKED : STORIES OF THE FUTURE PRESENT . In 2008, Tachyon Books published a collection of his essays, called CONTENT : SELECTED ESSAYS ON TECHNOLOGY , CREATIVITY, COPYRIGHT AND THE FUTURE OF THE FUTURE (with an introduction by John Perry Barlow) and IDW published a collection of comic books inspired by his short fiction called CORY DOCTOROW ’S FUTURISTIC TALES OF THE HERE AND NOW . His next novel is MAKERS , due from Tor Books/HarperCollins UK in October, 2009. He co-founded the open source peer-to-peer software company OpenCola, sold to OpenText, Inc in 2003, and presently serves on the boards and advisory boards of the Participatory Culture Foundation, the MetaBrainz Foundation, Technorati, Inc, the Organization for Transformative Works, Areae, the Annenberg Center for the Study of Online Communities, and Onion Networks, Inc. In 2007, Entertainment Weekly called him, “The William Gibson of his generation.” He was also named one of Forbes Magazine’s 2007/8 Web Celebrities, and one of the World Economic Forum’s Young Global Leaders for 2007. The title of his seminar is taken from a recent interview in which he described his distinctive approach to publishing his work and disseminating ideas. This talk is part of the Arcadia Project Seminars series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsDensity functional theory as an incitation to method develop new methods Molecules and genes in Alzheimer's RCEAL Tuesday ColloquiaOther talksAmino acid sensing: the elF2a signalling in the control of biological functions NatHistFest: the 99th Conversazione and exhibition on the wonders of the natural world. The genetics of depression Mechanistic model development to characterise drug effects on platelets over time in pharmaceutical research. Oncological imaging: introduction and non-radionuclide techniques Stereodivergent Catalysis, Strategies and Tactics Towards Secondary Metabolites as enabling tools for the Study of Natural Products Biology Fields of definition of Fukaya categories of Calabi-Yau hypersurfaces Art and Migration Molecular mechanisms of cardiomyopathies in patients with severe non-ischemic heart failure Networks, resilience and complexity Development of machine learning based approaches for identifying new drug targets |